By Katherine Hamilton
Tandem Diabetes Care has agreed to pay Roche Holding $36 million to settle a patent infringement claim.
The two companies have granted each other licenses to patents on the insulin delivery systems in question for the next 10 years, Tandem said Friday.
Swiss pharmaceutical company Roche filed an action in December 2023 alleging one of Tandem's insulin pumps infringed upon its patent. Roche was seeking monetary damages and for Tandem to stop selling the t:slim X2 pump.
San Diego-based Tandem will make an initial payment of $8 million under the agreement, and pay out the remaining balance in equal installments over the next four years.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
May 23, 2025 17:08 ET (21:08 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.